Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Highline Therapeutics and Weill Cornell Medical College are joining to fund and incubate translational research programs in New York City. The partners hope to establish spin-off companies backed by Versant Ventures, which operates Highline as a biotech incubator. The first program is in the areas of immunology and oncology. Larry Schlossman, Weill Cornell’s head of biopharma alliances and research collaborations, says Cornell “will be delivering on our mission to bring new therapies to patients and helping to foster a biotech ecosystem in New York City.”
This article has been sent to the following recipient: